| Igor Katsenelenbogen, | |
|
89 Nh Route 25, Meredith, NH 03253-6314 | |
| (603) 279-4551 | |
| Not Available |
| Full Name | Igor Katsenelenbogen |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 89 Nh Route 25, Meredith, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740688068 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | R1680 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Igor Katsenelenbogen, 111 Dix St, Bristol, NH 03222-5129 Ph: () - | Igor Katsenelenbogen, 89 Nh Route 25, Meredith, NH 03253-6314 Ph: (603) 279-4551 |
News Archive
Hypertension is skyrocketing in India, with rural-to-urban migrants at especially high risk. Hypertension will be a key theme at the 65th Annual Conference of the Cardiological Society of India, which takes place during 5-8 December in Bangalore, India, and features a collaborative programme with the European Society of Cardiology.
A combination of inexpensive oral medications may be able to treat fatigue-inducing anemias caused by chronic diseases and inflammation, a new discovery from the University of Virginia School of Medicine suggests.
Targeted interventions can significantly improve screening for diabetic retinopathy, a complication of diabetes and the leading cause of vision loss amongst working-age adults in the Western word, according to a new Cochrane Systematic Review.
'Smart' hand sanitizers that can provide data on workplace hand hygiene are being trialed across the country, as part of research by the Universities of Sheffield and Leeds into how best to engage people with the latest Covid-19 workplace hand hygiene guidance.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.
› Verified 6 days ago
Tracy Elizabeth Bourbeau, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 Nh Route 25, Meredith, NH 03253 Phone: 603-279-2230 | |
Ms. Carol A Walker, R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 31 Meredith Bay Dr, Meredith, NH 03253 Phone: 603-279-3037 | |
Hunter Paul Marcoux I, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 Nh Route 25 Unit 5, Meredith, NH 03253 Phone: 603-279-2230 | |
Dr. Liam Lombard, PHARM-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 Nh 25 Unit 5, Meredith, NH 03253 Phone: 603-279-2230 | |
Samuel Fiore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 89 Nh Route 25, Meredith, NH 03253 Phone: 603-253-5484 | |
Mr. Jay A. Hall, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 38 Nh Route 25, Meredith, NH 03253 Phone: 603-279-4551 |